TrialBMC cancer2019

A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA).

Nadja M Meindl-Beinker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.